0000874015-22-000069.txt : 20220202 0000874015-22-000069.hdr.sgml : 20220202 20220202192602 ACCESSION NUMBER: 0000874015-22-000069 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baroldi Joseph CENTRAL INDEX KEY: 0001813775 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 22585855 MAIL ADDRESS: STREET 1: C/O AVIDITY BIOSCIENCES, INC. STREET 2: 10975 N. TORREY PINES RD., SUITE 150 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 3 1 edgardoc.xml PRIMARY DOCUMENT X0206 3 2022-01-31 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001813775 Baroldi Joseph 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 Chief Business Officer Common Stock 3613 D Common Stock 322 I by Spouse Non-Qualified Stock Option (right to buy) 32.6 2023-01-03 2032-01-02 Common Stock 2849 I by Spouse Non-Qualified Stock Option (right to buy) 56.78 2022-01-04 2028-01-03 Common Stock 4924 I by Spouse Restricted Stock Unit 0.0 Common Stock 3066 I by Spouse Grant on 01/03/2022 to reporting person's spouse of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option will be vested and become exercisable on 01/03/2023. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments, at a rate of 712 shares per year. The option is exercisable as to 0 shares on 01/31/2022. Grant on 01/04/2021 to reporting person's spouse of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option vested and became exercisable on 01/04/2022. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments, at a rate of 1,231 shares per year. The option is exercisable as to 1,231 shares on 01/31/2022. Grants to reporting person's spouse of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan on January 15, 2021 and January 15, 2022. The restricted stock units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. By: Patrick R. O'Neil, attorney-in-fact For: Joseph T. Baroldi 2022-02-01